BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
5 hedge funds and large institutions have $29.5K invested in BIMI International Medical Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
91% less capital invested
Capital invested by funds: $346K → $29.5K (-$317K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$295K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$32.3K |
| 3 |
JP Morgan Chase
New York
|
-$2 |
BIMI Hedge Fund Activity: Q4 2023 in Review
5 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q4 2023, worth a combined $29.5K — down 91% from $346K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIMI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $1.56K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $295K sold.
- 5 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q4 2023, down from 6 in Q3 2023.
- Funds reported $29.5K of BIMI International Medical Inc. Common Stock stock for Q4 2023, down 91% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q4 2023 and 2 closed out, a net change of -1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q4 2023 was UBS Group, an estimated $1.56K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q4 2023 was Hudson Bay Capital Management, an estimated $295K sold.
Based on aggregated 13F filings for Q4 2023.